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A 48-year-old female with multiple myeloma (MM) and amyloidosis presented 
with massive upper gastrointestinal (GI) bleeding one week after autologous stem cell 
transplantation (autologous-SCT). Esophagogastroduodenoscopy (EGD) demonstrated 
necrotic, purple, pigmented, friable lesions throughout the stomach (Figure 1a), along 
with a bleeding ulcer in the cardia (Figure 1b, Video 1) which was successfully treated 
with epinephrine (1:10,000) injections. Biopsies demonstrated nodular amyloid 
deposition (Figures 2) which was Congo red positive. The patient had no further 
hematemesis and was discharged home 4 days later. Ten months after autologous-SCT, 
EGD revealed a normal stomach (Figure 3, Video 2) with no histologic evidence of 
amyloid. 
AL amyloid of the GI tract involves the stomach in 8% of cases [1]. Only 1% 
with gastric amyloidosis manifest symptoms such as bleeding [1,2], which has been 
attributed to light chain deposition in blood vessels causing increased friability and 
eventual bowel infarction [2,3]. Characteristic endoscopic findings include thickened 
folds, mucosal erosions, submucosal hematomas, ulcerations and mucosal friability [2]. 
Histology demonstrates deposition of amorphous hyaline material on H&E stain which is 
Congo-red stain positive. Treatment of AL amyloid is aimed at the underlying plasma 
cell disorder in order to decrease light chain production. High-dose melphalan followed 
by autologous-SCT induces a complete hematologic response, along with reversal of 
amyloid dependent organ dysfunction, in a majority of patients in about 3 months [4,5]. 
This therapy may be associated with significant toxicity, especially in patients with 
underlying cardiac disease.  
There is very limited published data documenting reversal of symptomatic GI 
amyloid with MM therapy [4,5]. We believe this is the first reported case of complete 
endoscopic and histologic resolution of GI amyloid, particularly amyloid induced GI 
bleeding, following autologous-SCT. In carefully selected patients with MM, high-dose 
melphalan followed by autologous-SCT may be effective for symptomatic AL amyloid of 
the GI tract. 
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 Figure Legend 
Video 1 Large ulcer in the cardia containing a bleeding pigmented lesion. Numerous 
additional lesions are present throughout the stomach which, upon probing, are friable 
and necrotic. 
 
Video 2 Complete resolution of gastric amyloid 10 months after autologous stem cell 
transplant. 
 
Figure 1a  A large pigmented lesion in the body of the stomach. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1b  Giant ulcer in the cardia containing a large, necrotic, bleeding pigmented 
lesion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2  Gastric biopsy with dense amyloid deposition in the mucosa at high 
magnification. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Normal gastric cardia and fundus 2 months after autologous stem cell transplant. 
 
 
 
